Boston Scientific Corp.

History

Year	Detail
Founding story	Boston Scientific Corp. has been established as a holding company in 1979.
1970s	The company's steerable catheters were firstly used in less-invasive procedures. In early 1970s, the company also introduced various new products such as Zavala Lung Model and lung cytology brush.
1980s
	Boston Scientific Corp. has acquired Kimray Medical Associates (KMA).
	In 1981, the company acquired Endo-Tech, who is a provider of gastrointestinal and pulmonary endoscopic accessories.
	In 1988, the introduction of Van-Tech has boosted the urology business with products such as pigtail ureteral stent.
1990s
	In May 19, 1992, Boston Scientific Corp. went into public through an IPO.
	By 1997, Boston Scientific Corp. has acquired nine companies with a revenue of around $1.8 billion.
	In 1998, Boston Scientific Corp. acquired Schneider Worldwide, which added necessary catheter and stent technologies to Boston Scientific's work in the area.
2000s	In 2004, Boston Scientific Corp. launched the TAXUS Express2, a paclitaxel-eluting coronary stent system in the U.S.
	The company also manufactured pulse generators and pain management systems.
	In 2004, the acquisition of Advanced Bionics has allowed company to enter into Neuromodulation.
	In 2006, the acquisition of Guidant has enabled company to be one of the leading company for cardiovascular medicines and largest medical devices globally.
2010s
	Boston Scientific Corp. launched Promus Element, a drug-eluting coronary stent system; S-ICD System, a subcutaneous implantable defibrillator; Alair Bronchial Thermplasty System used for the treatment of asthma; and Precision Plus Spinal Cord Stimulation System, which will be used to manage chronic pain of the trunk and limbs.